tci Medicare Compliance & Reimbursement - 2023 Issue Q3
Industry Notes: Regulatory Saga for Medicare Coverage of Emerging Tech Continues
With twists and turns aplenty, the Centers for Medicare & Medicaid Services (CMS) has finally issued a notice on how it plans to offer access to emerging technologies and devices, cover the innovations, and protect beneficiaries. First: In September 2021, CMS repealed the ‘‘Medicare Program; Medicare Coverage of Innovative Technology (MCIT) and Definition of ‘Reasonable and Necessary’” final rule because the agency found the research lacking and wanted more study and regulation over Food and Drug Administration (FDA)-designated breakthrough devices (see Medicare Compliance & Reimbursement, Vol. 47, No. 20). Next: In November 2022, CMS released...
To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.
Thank you for choosing Find-A-Code, please Sign In to remove ads.